Loading…
Employees: 6,885
Size Kovai Medical Center & Hospital (KOVAI.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $689M, the 724th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹5,948 on 6 Nov 2026.
Performance Over six months the shares gained 4.1%, against -2.2% for the median peer and 0.0% for the India market (cap-weighted) — 8th highest of 20 in its peer set.
Growth Revenue grew 15.0% over the last twelve months (peer median +8.7%); the operating margin is 20.9% (peer median 10.4%).
Valuation It trades at 4.0× enterprise value to sales against a peer median of 2.6× (8th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +18%, so the hurdle is -2 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 8.0 points above its cost of capital (11.4% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹16.4B | ₹15.8B | ₹13.7B | ₹12.2B | ₹10.2B |
| Revenue growth | — | +16% | +12% | +20% | — |
| Gross profit | ₹5.35B | ₹4.08B | ₹3.54B | ₹3.15B | ₹3.86B |
| EBITDA | ₹4.58B | ₹4.48B | ₹3.93B | ₹3.47B | ₹2.75B |
| Net income | ₹2.53B | ₹2.44B | ₹2.09B | ₹1.80B | ₹1.16B |
| Free cash flow | n/a | ₹1.02B | -₹294M | ₹1.77B | ₹990M |
| Capital expenditure | n/a | ₹2.52B | ₹3.53B | ₹1.38B | ₹1.27B |
| Total debt | n/a | ₹4.03B | ₹4.15B | ₹3.10B | ₹5.11B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | KOVAI.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +0.5% | -0.7% | 8th highest of 20 |
| 6-month return | +4.1% | -2.2% | 8th highest of 20 |
| Distance from 52-week high | -7.7% | -19.2% | 3rd highest of 20 |
| Revenue growth (TTM) | +15.0% | +8.7% | 6th highest of 21 |
| Operating margin | 20.9% | 10.4% | 3rd highest of 20 |
| EV / Sales | 4.0× | 2.6× | 8th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 16.3% | 6.3% | 6th most demanding of 16 |
| Growth delivered (Del g) | +18.1% | +11.8% | 6th highest of 16 |
| Hurdle (Req g minus delivered) | -1.8 pp | -1.6 pp | 8th least demanding of 16 |
| ROIC minus cost of capital | +8.0 pp | -1.5 pp | 3rd highest of 20 |
| EV / EBITDA | 14.2× | 10.9× | 9th most expensive of 18 |
| Net debt / EBITDA | 0.1× | 0.7× | 6th least indebted of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Kovai Medical Center & Hospital KOVAI.NS | India | $689M | +4% | +15% | 21% | 4.0× | 16.3% | +18.1% |
| Paras Healthcare PARASHLTH.NS | India | $844M | n/a | +24% | 11% | 5.6× | n/a | n/a |
| Garofalo Health Care GHC.MI | Italy | $540M | +1% | +4% | 10% | 1.5× | 1.8% | +18.3% |
| Artemis Medicare Services ARTEMISMED.NS | India | $514M | +16% | +15% | 14% | 4.4× | 45.8% | +21.5% |
| Clinica Baviera CBAV.MC | Spain | $940M | -7% | +11% | 20% | 2.5× | 0.7% | +19.7% |
| HealthCare Global Enterprises HCG.NS | India | $950M | -2% | +14% | 8% | 3.4× | n/a | n/a |
| Thomson Medical A50.SI | Singapore | $953M | -21% | +6% | 10% | 5.5× | 20.9% | +11.8% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1,000M | +14% | +17% | 16% | 6.0× | n/a | n/a |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.05B | +25% | +50% | 16% | 6.8× | n/a | n/a |
| Bayzed Health 2609.HK | Hong Kong | $453M | -49% | -2% | 5% | 2.9× | 17.4% | +9.2% |
| Rhon-klinikum RHK.DE | Germany | $1.08B | +14% | +5% | 3% | 0.6× | n/a | n/a |
| Ramsay Generale de Sante GDS.PA | France | $1.09B | -15% | +3% | 4% | 0.9× | 6.3% | +6.0% |
| Bright Eye Hospital 301239.SZ | China | $419M | -23% | +11% | 9% | 1.4× | -3.7% | +15.5% |
| China Resources Medical 1515.HK | Hong Kong | $415M | -12% | 0% | 6% | 0.5× | -7.3% | +26.3% |
| Park Medi World PARKHOSPS.NS | India | $1.15B | +2% | +21% | n/a | 8.1× | 30.5% | +10.2% |
| Voxel VOX.WA | Poland | $405M | +50% | +14% | 24% | 2.7× | 1.1% | +12.2% |
| CVS CVSG.L | United Kingdom | $1.23B | +20% | +6% | 11% | 1.7× | 13.7% | +6.9% |
| Raffles Medical BSL.SI | Singapore | $1.25B | -15% | -3% | 11% | 1.8× | -2.4% | +6.1% |
| Liaoning He Eye Hospital 301103.SZ | China | $365M | -21% | +3% | 4% | 1.1× | -2.1% | +5.4% |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.34B | -4% | +23% | 22% | 6.9× | 30.2% | +21.2% |
| Spire Healthcare SPI.L | United Kingdom | $1.34B | +68% | +2% | 8% | 1.4× | 9.8% | +11.4% |